150
Participants
Start Date
March 21, 2022
Primary Completion Date
September 30, 2032
Study Completion Date
September 30, 2045
Mesalamine
The IMP will be supplied as sachets with slow-releasing granules.
Placebo
The IMP will be supplied as sachets with slow-releasing granules.
RECRUITING
Hvidovre Hospital, Hvidovre
NOT_YET_RECRUITING
Aalborg University Hospital, Aalborg
RECRUITING
Sahlgrenska University Hsospital, Gothenburg
RECRUITING
Skåne University Hospital, Malmo
RECRUITING
Ersta Hospital/Ersta Diakoni, Stockholm
ACTIVE_NOT_RECRUITING
Karolinska University Hospital, Stockholm
RECRUITING
Norrland University Hospital, Umeå
NOT_YET_RECRUITING
Akademiska hospital, Uppsala
The Swedish Research Council
OTHER_GOV
Karolinska Institutet
OTHER
Ann-Sofie Backman
OTHER